Mar. 26. 2018
Osaka, Japan – March 26, 2018 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) today announced the following organizational and personnel changes, effective April 1, 2018.
1. Organizational Changes
“Development QA” is renamed to “QA Department”.
※QA Department is for integrating and strengthening the quality assurance(QA) function at Research and Development division.
2. Personnel Changes
(1) Executive officer (Effective April 1, 2018)
| Name | New Post | Current Post |
|---|---|---|
| Kyozo Inari | Executive Officer, Super Visor of External Affairs Department | Executive Officer, General Manager of External Affairs Department |
(2) General Managers (Effective April 1, 2018)
| Name | New Responsibility | Current Responsibility |
|---|---|---|
| Yoshiomi Kunihiro | General Manager of External Affairs Department | Executive Specialist of External Affairs |
| Tooru Shinki | General Manager of Sapporo Branch and Manager of Hospital Section | Manager of Sales Section, Tokyo Daini Branch |
| Yoshiki Ozawa | General Manager of Development Department | Group Manager of Regulatory Affairs Group, Development Department |
| Hiromu Toyoda | General Manager of QA Department | General Manager of Development QA |